Literature DB >> 18566789

[Hans Steinert: 100 years of myotonic dystrophy].

H Steinberg1, A Wagner.   

Abstract

This study includes for the first time detailed biographical facts about Hans Steinert (1875-1911), who in 1909 first described myotonic dystrophy (Steinert's disease) as an independent syndrome. Of utmost importance are Steinert's years at the medical hospital of Leipzig University, where in 1901 he became the assistant of his mentor Heinrich Curschmann (1846-1910). Shortly after being appointed Extraordinary Professor there, Steinert died at the age of 36. As early as 1912 Hans Curschmann (1875-1950) fully recognized the importance of Steinert's pioneering work. Referring to key passages in his 1909 investigation, this study demonstrates how, on the basis of precise observation, subtle neurologic examination, and great clinical experience, Steinert succeeded in identifying a syndrome that to this day plays an important role in neurologic practice.

Entities:  

Mesh:

Year:  2008        PMID: 18566789     DOI: 10.1007/s00115-008-2502-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  3 in total

1.  Myotonic dystrophy.

Authors:  Jeffrey J Tramonte; Ted M Burns
Journal:  Arch Neurol       Date:  2005-08

2.  [Hans Curschmann].

Authors:  M NONNE
Journal:  Dtsch Z Nervenheilkd       Date:  1950

Review 3.  [Dystrophia myotonica (Steinert disease)--a frequently misdiagnosed disease].

Authors:  E Kuhn; F Lehmann-Horn; R Rüdel
Journal:  Nervenarzt       Date:  1990-06       Impact factor: 1.214

  3 in total
  2 in total

1.  Adolf von Strümpell: a key yet neglected protagonist of neurology.

Authors:  Birk Engmann; Armin Wagner; Holger Steinberg
Journal:  J Neurol       Date:  2012-04-19       Impact factor: 4.849

2.  Clinical, pathological and genetic characteristics of a pedigree with myotonic dystrophy type 1.

Authors:  Qing Liu; Yu-Fei Zheng; Yan-Ping Zhu; Shi-Qing Ling; Wei-Rong Li
Journal:  Exp Ther Med       Date:  2015-09-09       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.